Adoption of the accounts and discharge from liability
The Annual General Meeting adopted the income statement and balance sheet for the Company and the Group for 2023. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2023.

Allocation of profit
The Annual General Meeting resolved, in accordance with the Board of Directors' proposal, that no dividend will be paid for the financial year 2023 and that the result for the year shall be carried forward.

Board of Directors and auditors
The Annual General Meeting resolved that the number of Board members shall be five Board members without deputies and that the Company shall have one auditor and one deputy auditor.

Furthermore, the Annual General Meeting resolved to re-elect Ingemar Andersson, Christer Nygren, Mats W Lundberg, Thomas Nygren and Marie Brodin as Board members and to re-elect Ingemar Andersson as Chairman, all for the period until the end of the Annual General Meeting 2025.

It was resolved to re-elect Tomas Nöjd as the Company's auditor with Camilla Beijron as deputy auditor for the period until the end of the Annual General Meeting 2025.

Remuneration
The Annual General Meeting resolved that the Chairman shall be paid SEK 280,000 and each of the other members shall be paid SEK 140,000. It was further resolved that fees to the auditor shall be paid in accordance with approved invoices.

Nomination committee
The Annual General Meeting resolved to establish a Nomination Committee in the Company, which shall consist of one representative for each of the two largest known shareholders in terms of voting rights in the Company as of 31 December. Furthermore, the Chairman of the Board is a member of the Nomination Committee.

Amendment of the Articles of Association
The Annual General Meeting resolved to amend the Articles of Association. The complete proposal to amend the Articles of Association is included in the notice to the Annual General Meeting which was published by press release on 7 May 2024.

Authorization to issue new shares
The Annual General Meeting resolved to authorize the Board of Directors to, on one or several occasions, resolve to issue shares, warrants and/or convertibles. The authorization shall include the right to deviate from the shareholders' preferential rights and the right to resolve on issues to be paid by way of cash consideration, non-cash consideration or by way of set-off. The Company's share capital and the number of shares may, by virtue of the authorization, increase by a maximum amount and number of shares, respectively, that falls within the limits of the Articles of Association.

Minutes of the Annual General Meeting and complete resolutions
The minutes from the Annual General Meeting, including the complete resolutions, will be available at the Company and on the Company's website, www.metacon.com

For further information, contact Christer Wikner, by phone 0707-647389 or e-mail info@metacon.com

About Metacon AB (publ)
Metacon AB (publ) develops and manufactures energy systems for the production of fossil-free "green" hydrogen. The products in the Reformation business area are based, among other things, on a patented technology that generates hydrogen through catalytic steam reforming of biogas or other hydrocarbons. The development of Metacon's reforming products is carried out within the wholly owned subsidiary Metacon S.A in Patras, Greece. The business is focused on catalytic process chemistry and advanced reformers for high-efficiency hydrogen production.

Metacon also offers complete electrolysers and integrated refuelling stations for green hydrogen, a large and globally growing area for the production of green hydrogen. Electrolysis is a process of driving a chemical reaction to split water by adding electricity. If the electricity used is non-fossil, hydrogen will also be fossil-free and climate-neutral. Green hydrogen can be used in the transport sector, basic industry and the real estate sector, among others, with a better environment and climate as a result. https://metacon.com/

For further information, see:
www.metacon.com | Twitter: @Metaconab| LinkedIn: www.linkedin.com/company/metaconab